Reuters - Shares of Depomed Inc fell as much as 29 percent to their lowest in a year, after the specialty pharmaceutical company said its experimental drug to treat menopausal hot flashes showed mixed results in a late-stage study.
You are here:
Health 
Diseases & Conditions Mixed data on hot flashes drug drags Depomed to year
(Reuters)
Diseases & Conditions Mixed data on hot flashes drug drags Depomed to year
(Reuters)
